Pulmonary hypertension in polymyositis-dermatomyositis: clinical and hemodynamic characteristics and response to vasoactive therapy
Author:
- 17 September 2009
- journal article
- case report
- Published by SAGE Publications in Lupus
- Vol. 18 (11) , 1006-1010
Abstract
The increased incidence of pulmonary hypertension and its association with decreased survival is well-recognised in patients with systemic sclerosis. This association is not widely appreciated in patients with polymyositis-dermatomyositis. We report clinical and hemodynamic characteristics and response to vasoactive therapy in three patients with polymyositis-dermatomyositis and pulmonary hypertension and discuss them in light of the available literature.Keywords
This publication has 13 references indexed in Scilit:
- Lupus-associated pulmonary hypertension: Long-term response to vasoactive therapyRespiratory Medicine, 2007
- Pulmonary Complications of Polymyositis and DermatomyositisSeminars in Respiratory and Critical Care Medicine, 2007
- Pulmonary Vascular Manifestations of Mixed Connective Tissue DiseaseRheumatic Disease Clinics of North America, 2005
- Severe, Reversible Pulmonary Hypertension in a Patient With Monoclonal Gammopathy and Features of DermatomyositisMayo Clinic Proceedings, 2004
- Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvementArthritis & Rheumatism, 2003
- Pulmonary hypertension in systemic sclerosis: an analysis of 17 patientsRheumatology, 1996
- Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung compliance.Annals of the Rheumatic Diseases, 1993
- Pulmonary hypertension in the crest syndrome variant of systemic sclerosisArthritis & Rheumatism, 1986
- Cardiac involvement in polymyositisArthritis & Rheumatism, 1979
- PULMONARY HYPERTENSION IN DERMATOMYOSITISHeart, 1956